[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 652
Citations 0
Correction
March 2017

Supplement 2 Added

Author Affiliations
 

Copyright 2017 American Medical Association. All Rights Reserved.

JAMA Oncol. 2017;3(3):418. doi:10.1001/jamaoncol.2016.6886

In the Brief Report titled “Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases,”1 published online December 7, 2016, Supplement 2 was omitted when the article was initially published. This article was corrected online.

References
1.
Priedigkeit  N, Hartmaier  RJ, Chen  Y,  et al.  Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases  [published online December 7, 2016].  JAMA Oncol. doi:10.1001/jamaoncol.2016.5630PubMedGoogle Scholar
×